Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) announces its human-machine hybrid digital “mind”
August 10, 2021
Ryan Allway August 10th, 2021 Psychedelics, Top News Calgary, Alberta – TheNewswire -August 10, 2021 – (CNSX:MXT.CN) (OTC:MSTTE) “Computers are fast, accurate and stupid. Humans are slow, inaccurate and brilliant. Together they are powerful beyond imagination” – Albert Einstein The Corporation reports that it’s contracted medical professionals (see bios below) have begun generating a series... Read more
Delic Labs Scientific Advisor Professor Glenn Sammis Receives Full Professorship at University of British Columbia
August 10, 2021
Ryan Allway August 10th, 2021 Psychedelics Professor Sammis takes sabbatical to devote significant time toward developing psilocybin and cannabis intellectual property (IP) for Delic Labs VANCOUVER, BC, Aug. 10, 2021 /PRNewswire/ – Delic Corp Inc. (“DELIC” or the “Company“) (CSE: DELC) (OTCQB: DELCF), the leading psychedelic wellness platform, today announced Professor Glenn Sammis, Scientific Advisor of... Read more
Ryan Allway August 5th, 2021 Psychedelics CAPE TOWN, SA / ACCESSWIRE / August 5, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) (“Wuhan” or the “Company”), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research, is pleased to announce the following corporate update: The research team funded... Read more
Unlocking the potential of psychedelics, including DMT, and other tryptamines to treat the significant unmet medical needs of glaucoma patients Partnering with world-renowned research institution brings validated drug delivery expertise in novel, controlled drug-release technologies Toronto, Ontario–(Newsfile Corp. – August 5, 2021) – PharmaDrug Inc. (CSE: PHRX) (OTC Pink:... Read more
Ryan Allway August 2nd, 2021 Psychedelics ADELAIDE, Australia, Aug. 2, 2021 /PRNewswire/ — Bionomics Limited (ASX: BNO,OTCQB: BNOEF), (Bionomics) a global, clinical stage biopharmaceutical company, is pleased to announce that it plans to conduct a registered initial public offering of American Depositary Shares (ADSs) in the United States and a... Read more
Entheon Biomedical Corp. Acquires Lobo Genetics Inc.
July 30, 2021
Ryan Allway July 30th, 2021 Psychedelics Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols Vancouver, British Columbia–(Newsfile Corp. – July 30, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company completed its acquisition... Read more
New CBD Trials Point the Way for Enveric, MagicMed
CBD July 30, 2021
Ryan Allway July 30th, 2021 Psychedelics, Top Story As the cannabis industry strives to gain widespread acceptance in the mainstream, scientific studies into the potential benefits of the plant and its active ingredients play a key role in reaching that goal. There are currently very few approved pharmaceutical drug... Read more
Regulatory Approvals Place Filament Health at the Forefront of Natural Psychedelic Research and Manufacturing
July 29, 2021
Ryan Allway July 29th, 2021 Psychedelics Health Canada Dealer’s License to allow the possession, production, and delivery of all controlled natural psychedelic substances VANCOUVER, BC , July 29, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (“Filament” or the “Company”), a global leader in natural psychedelic drug development, has been granted an amendment to its... Read more
Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) announces a Business Refocus
July 27, 2021
Ryan Allway July 27th, 2021 Psychedelics, Top News Calgary, Alberta –TheNewswire – July 27, 2021 – Medxtractor (“MedX” or the “Corporation”) (CSE:MXT), (CNSX:MXT.CN),(OTC:MXTTF) reports its plan to refocus to proprietary health-related databases, machine-learning analysis and associated applications. The planned changes are generally as follows: Continuing development of the proprietary health-related Reference Database (“RD”) and... Read more
Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent
July 27, 2021
Ryan Allway July 27th, 2021 Psychedelics, Top News Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB:SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announcedthat the United States... Read more
